Linked from

The 24 pages that link to Hypokalemia, each with the reason it gives.

• PotassiumRelated: Insufficient extracellular potassium can disturb electrical activity in muscles and the heart.

• HyperkalemiaCompared with: It is the opposite potassium imbalance and can produce different, sometimes overlapping, ECG changes.

• Diabetic ketoacidosisRelated: Insulin and correction of acidosis can expose or worsen potassium depletion.

• Potassium chlorideRelated: Potassium chloride is a common treatment for restoring potassium in hypokalemia.

• Potassium ionRelated: Low extracellular K⁺ can impair muscle and cardiac function.

• Electrolyte imbalanceBroader topic: Low potassium can cause weakness, abnormal heart rhythms, and characteristic electrocardiogram changes.

• Thiazide diureticRelated: Increased potassium loss in urine is a recognized effect of thiazide therapy.

• Renal tubular acidosisRelated: Types 1 and 2 commonly cause potassium loss, shaping symptoms and treatment choices.

• Torsades de pointesRelated: Low potassium can prolong repolarization and increase susceptibility to torsades.

• HypomagnesemiaCompared with: It can coexist with low magnesium, but requires its own laboratory assessment and treatment.

• Primary aldosteronismRelated: Aldosterone-driven kidney potassium loss can produce this finding, though many affected people have normal potassium.

• FludrocortisoneRelated: Increased renal potassium excretion can make this a consequence of fludrocortisone treatment.

• Loop diureticRelated: Increased distal sodium delivery can promote urinary potassium loss during loop-diuretic treatment.

• DigoxinRelated: Low potassium can increase digoxin binding to Na⁺/K⁺-ATPase and raise toxicity risk.

• Amphotericin BRelated: Kidney tubular effects during amphotericin B treatment can increase potassium loss.

• DiureticsRelated: Loop and thiazide diuretics can increase urinary potassium loss.

• Liddle syndromeRelated: It is a common biochemical consequence of increased kidney potassium secretion in Liddle syndrome.

• Bartter syndromeRelated: Renal potassium loss, amplified by aldosterone, is a defining biochemical consequence.

• Gitelman syndromeRelated: Potassium depletion is a defining biochemical feature and can cause weakness or cramps.

• FurosemideRelated: Increased delivery of sodium to later nephron segments can increase potassium loss during treatment.

• HydrochlorothiazideRelated: Increased distal sodium delivery can promote urinary potassium loss.

• Hypokalemic periodic paralysisNarrower topic: It is the defining laboratory abnormality during many attacks, but does not alone identify their cause.

• HyperaldosteronismRelated: Renal potassium loss from aldosterone excess can produce this electrolyte disturbance.

• TubulopathyRelated: Several salt-wasting tubulopathies increase urinary potassium loss.